Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT01383148 · TERMINATED

Trial details

NCT number: NCT01383148
Sponsor: Transgene
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2012-04-01
Primary completion: 2015-07-01
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.